Sumitomo Life Insurance CO Biogen Inc. Transaction History

Sumitomo Life Insurance CO

$4.61 Billion
Q2 2024

A detailed history of Sumitomo Life Insurance CO transactions in Biogen Inc. stock. As of the latest transaction made, Sumitomo Life Insurance CO holds 3,744 shares of BIIB stock, worth $732,438. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,744

Previous 4,205 10.96%

Holding current value

$732,438

Previous $906,000 4.3%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$190.52 - $236.72 $87,829 - $109,127	-461 Reduced 10.96%	3,744 $867,000
Q1 2024 Apr 26, 2024	SELL	$212.02 - $267.71 $39,435 - $49,794	-186 Reduced 4.24%	4,205 $906,000
Q4 2023 Jan 30, 2024	SELL	$222.59 - $267.94 $50,750 - $61,090	-228 Reduced 4.94%	4,391 $1.14 Million
Q3 2023 Oct 23, 2023	SELL	$253.3 - $285.89 $15,451 - $17,439	-61 Reduced 1.3%	4,619 $1.19 Million
Q2 2023 Jul 20, 2023	SELL	$275.25 - $318.06 $120,559 - $139,310	-438 Reduced 8.56%	4,680 $1.33 Million
Q1 2023 Apr 27, 2023	SELL	$256.56 - $292.34 $13,341 - $15,201	-52 Reduced 1.01%	5,118 $1.42 Million
Q4 2022 Jan 17, 2023	SELL	$252.44 - $306.72 $70,178 - $85,268	-278 Reduced 5.1%	5,170 $1.43 Million
Q3 2022 Oct 31, 2022	SELL	$194.69 - $268.46 $77,486 - $106,847	-398 Reduced 6.81%	5,448 $1.46 Million
Q2 2022 Jul 22, 2022	BUY	$187.54 - $223.02 $36,007 - $42,819	192 Added 3.4%	5,846 $1.19 Million
Q1 2022 Apr 27, 2022	SELL	$193.77 - $244.14 $37,203 - $46,874	-192 Reduced 3.28%	5,654 $1.19 Million
Q4 2021 Feb 04, 2022	SELL	$223.92 - $287.77 $35,155 - $45,179	-157 Reduced 2.62%	5,846 $1.4 Million
Q3 2021 Oct 25, 2021	SELL	$282.99 - $369.05 $71,879 - $93,738	-254 Reduced 4.06%	6,003 $1.7 Million
Q2 2021 Jul 20, 2021	SELL	$259.0 - $414.71 $252,266 - $403,927	-974 Reduced 13.47%	6,257 $2.17 Million
Q1 2021 Apr 27, 2021	SELL	$242.95 - $284.63 $72,642 - $85,104	-299 Reduced 3.97%	7,231 $2.02 Million
Q4 2020 Feb 05, 2021	SELL	$236.26 - $355.63 $208,853 - $314,376	-884 Reduced 10.51%	7,530 $1.84 Million
Q3 2020 Oct 29, 2020	SELL	$264.77 - $305.71 $116,234 - $134,206	-439 Reduced 4.96%	8,414 $2.39 Million
Q2 2020 Jul 22, 2020	SELL	$258.66 - $342.55 $193,219 - $255,884	-747 Reduced 7.78%	8,853 $2.37 Million
Q1 2020 May 01, 2020	BUY	$268.85 - $341.04 $34,950 - $44,335	130 Added 1.37%	9,600 $3.04 Million
Q4 2019 Jan 24, 2020	BUY	$220.06 - $304.07 $117,291 - $162,069	533 Added 5.96%	9,470 $2.81 Million
Q3 2019 Oct 24, 2019	SELL	$217.44 - $243.88 $248,316 - $278,510	-1,142 Reduced 11.33%	8,937 $2.08 Million
Q2 2019 Jul 26, 2019	BUY	$219.29 - $241.72 $89,251 - $98,380	407 Added 4.21%	10,079 $2.36 Million
Q1 2019 Apr 17, 2019	SELL	$216.71 - $338.96 $242,931 - $379,974	-1,121 Reduced 10.39%	9,672 $2.29 Million
Q4 2018 Jan 24, 2019	BUY	$278.5 - $352.75 $78,815 - $99,828	283 Added 2.69%	10,793 $3.25 Million
Q3 2018 Oct 18, 2018	SELL	$293.51 - $383.83 $52,244 - $68,321	-178 Reduced 1.67%	10,510 $3.71 Million
Q2 2018 Jul 23, 2018	BUY	$257.52 - $306.91 $1.12 Million - $1.33 Million	4,340 Added 68.37%	10,688 $3.1 Million
Q1 2018 Apr 27, 2018	SELL	$260.13 - $367.91 $72,836 - $103,014	-280 Reduced 4.22%	6,348 $1.74 Million
Q4 2017 Feb 01, 2018	SELL	$307.64 - $344.58 $98,752 - $110,610	-321 Reduced 4.62%	6,628 $2.11 Million
Q3 2017 Oct 17, 2017	BUY	$281.15 - $329.69 $1.95 Million - $2.29 Million	6,949	6,949 $2.18 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Life Insurance CO with notifications on news.

Account

Sumitomo Life Insurance CO Biogen Inc. Transaction History